Evidence map›Paper›PMID 36412878›Full record

ArticleJournal of functional biomaterials2022

Annabelle Vigué, Dominique Vautier, Amad Kaytoue, Bernard Senger, Youri Arntz, Vincent Ball, Amine Ben Mlouka, Varvara Gribova, Samar Hajjar-Garreau, Julie Hardouin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Annabelle ViguéINSERM UMR-S 1121 Biomaterial Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, 67084 Strasbourg, France.
Dominique VautierINSERM UMR-S 1121 Biomaterial Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, 67084 Strasbourg, France.
Amad KaytoueINSERM UMR-S 1121 Biomaterial Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, 67084 Strasbourg, France.
Bernard SengerINSERM UMR-S 1121 Biomaterial Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, 67084 Strasbourg, France.ORCID 0000-0003-0955-7019
Youri ArntzINSERM UMR-S 1121 Biomaterial Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, 67084 Strasbourg, France.ORCID 0000-0002-1897-6349
Vincent BallINSERM UMR-S 1121 Biomaterial Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, 67084 Strasbourg, France.ORCID 0000-0002-7432-4222
Amine Ben MloukaPISSARO Proteomic Facility, IRIB, 76130 Mont-Saint-Aignan, France.
Varvara GribovaINSERM UMR-S 1121 Biomaterial Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, 67084 Strasbourg, France.
Samar Hajjar-GarreauMulhouse Materials Science Institute, CNRS/Haute Alsace University, 68057 Mulhouse, France.
Julie HardouinPISSARO Proteomic Facility, IRIB, 76130 Mont-Saint-Aignan, France.ORCID 0000-0003-4588-9811
Thierry JouennePISSARO Proteomic Facility, IRIB, 76130 Mont-Saint-Aignan, France.ORCID 0000-0003-0994-9944
Philippe LavalleINSERM UMR-S 1121 Biomaterial Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, 67084 Strasbourg, France.
Lydie PlouxINSERM UMR-S 1121 Biomaterial Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, 67084 Strasbourg, France.
Inserm · FRCentre National de la Recherche Scientifique · FRDifférenciation et Communication Neuronale et Neuroendocrine · FR

Funding

Region Grand Est ERMES project
6 · The paper itself

Abstract

The surface stiffness of the microenvironment is a mechanical signal regulating biofilm growth without the risks associated with the use of bioactive agents. However, the mechanisms determining the expansion or prevention of biofilm growth on soft and stiff substrates are largely unknown. To answer this question, we used PDMS (polydimethylsiloxane, 9-574 kPa) and HA (hyaluronic acid gels, 44 Pa-2 kPa) differing in their hydration. We showed that the softest HA inhibited Escherichia coli biofilm growth, while the stiffest PDMS activated it. The bacterial mechanical environment significantly regulated the MscS mechanosensitive channel in higher abundance on the least colonized HA-44Pa, while Type-1 pili (FimA) showed regulation in higher abundance on the most colonized PDMS-9kPa. Type-1 pili regulated the free motion (the capacity of bacteria to move far from their initial position) necessary for biofilm growth independent of the substrate surface stiffness. In contrast, the total length travelled by the bacteria (diffusion coefficient) varied positively with the surface stiffness but not with the biofilm growth. The softest, hydrated HA, the least colonized surface, revealed the least diffusive and the least free-moving bacteria. Finally, this shows that customizing the surface elasticity and hydration, together, is an efficient means of affecting the bacteria's mobility and attachment to the surface and thus designing biomedical surfaces to prevent biofilm growth.

Indexed as

bacterial mobilitybiofilmhyaluronic acidhydrationpolydimethylsiloxane (PDMS)protein patternssurface stiffness

Identifiers

PMID36412878
PMCPMC9680287
OpenAlexW4309004482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.